Further, knockdown of ZFX has been reported to inhibit cellular proliferation in human laryngeal squamous cell carcinoma, gastric cancer, malignant glioma, non-small cell lung carcinoma and prostate cancer [28-32]. Here, ZFX is linked to prostate carcinoma.